[1]
“Efficacy of Neoadjuvant Endocrine Therapy Compared to Chemotherapy in ER+HER2-Negative Breast Cancer in Postmenopausal Patients: Preliminary Results of a Single-Center Matched-Cohort Study”, Вопр. онкол., vol. 71, no. 3, p. OF-2304, Jun. 2025, doi: 10.37469/0507-3758-2025-71-3-OF-2304.